| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Total revenues [+] | 31.7 | 32.4 | 38.8 | 38.7 | 45.9 | 134.0 | 156.5 | 111.0 |
| Products | | | | | | | 152.7 | 107.4 |
| Services | | | | | | | 3.8 | 3.6 |
| Net interest income | | | -0.4 | -1.1 | -1.2 | -1.4 | -1.5 | -1.6 |
| Revenue growth | -2.2% | -16.5% | 0.2% | -15.5% | -65.8% | -14.4% | 40.9% | 7.5% |
| Cost of goods sold [+] | 14.0 | 14.3 | 16.5 | 16.8 | 18.0 | 77.6 | 89.3 | 62.2 |
| Cost of product sales | | | | | | | 87.1 | 59.7 |
| Cost of services | | | | | | | 2.3 | 2.5 |
| Gross profit | 17.7 | 18.1 | 22.3 | 21.9 | 27.8 | 56.5 | 67.2 | 48.9 |
| Gross margin | 55.7% | 55.8% | 57.4% | 56.6% | 60.7% | 42.1% | 42.9% | 44.0% |
| Selling, general and administrative [+] | 12.5 | 14.3 | 17.1 | 22.8 | 23.7 | 36.5 | 43.6 | 42.7 |
| Sales and marketing | 5.5 | 6.2 | 7.8 | 9.1 | 9.1 | 21.5 | 25.7 | 25.1 |
| General and administrative | 7.0 | 8.1 | 9.2 | 13.7 | 14.6 | 15.1 | 17.9 | 17.6 |
| Research and development | 9.3 | 8.3 | 9.7 | 9.5 | 10.9 | 30.0 | 34.8 | 34.8 |
| Other operating expenses | 0.5 | -0.8 | -0.8 | -4.3 | 4.2 | 0.4 | 0.0 | -0.4 |
| EBITDA [+] | -4.2 | -3.1 | -2.0 | -2.8 | -6.9 | -3.8 | -5.3 | -21.5 |
| EBITDA growth | 33.4% | 57.8% | -27.8% | -60.1% | 79.9% | -27.2% | -75.4% | -10.9% |
| EBITDA margin | -13.3% | -9.7% | -5.1% | -7.1% | -15.1% | -2.9% | -3.4% | -19.4% |
| Depreciation | 0.2 | 0.3 | 1.5 | 3.3 | 4.0 | 6.6 | 5.9 | 6.7 |
| EBITA | -4.4 | -3.4 | -3.5 | -6.0 | -10.9 | -10.4 | -11.2 | -28.2 |
| EBITA margin | -14.0% | -10.5% | -9.1% | -15.6% | -23.9% | -7.8% | -7.2% | -25.4% |
| Amortization of intangibles | 0.2 | 0.2 | 0.2 | 0.1 | | | | |
| EBIT [+] | -4.7 | -3.6 | -3.8 | -6.1 | -10.9 | -10.4 | -11.2 | -28.2 |
| EBIT growth | 28.0% | -3.4% | -38.5% | -44.1% | 4.9% | -6.9% | -60.3% | -7.7% |
| EBIT margin | -14.7% | -11.2% | -9.7% | -15.8% | -23.9% | -7.8% | -7.2% | -25.4% |
| Non-recurring items [+] | | 0.3 | 5.7 | 8.2 | 2.3 | 1.2 | | 1.2 |
| Asset impairment | | | 5.7 | 7.8 | | | | |
| Unusual expense | | | | | 3.5 | | | |
| Legal settlement | | | | | 3.5 | | | |
| Loss on contingent liability | | | | | 3.5 | | | |
| Other income (expense), net [+] | 0.5 | -0.8 | -4.1 | -0.9 | 0.7 | 0.4 | 0.0 | -0.4 |
| Gain (loss) on debt retirement | | | 3.3 | | | | | |
| Pre-tax income | -4.2 | -4.7 | -13.6 | -15.2 | -12.5 | -11.2 | -11.2 | -29.8 |
| Income taxes | 0.0 | 0.2 | 0.1 | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 |
| Tax rate | 0.7% | | | | | | | |
| Earnings from continuing ops | -4.6 | -4.1 | -13.2 | -6.4 | -11.1 | -13.2 | -13.0 | -31.3 |
| Earnings from discontinued ops | | | | -9.3 | -3.7 | | | |
| Net income | -4.6 | -4.1 | -13.2 | -15.6 | -14.7 | -13.2 | -13.0 | -31.3 |
| Net margin | -14.6% | -12.7% | -34.1% | -40.3% | -32.1% | -9.8% | -8.3% | -28.2% |
| |
| Basic EPS [+] | ($1.04) | ($0.93) | ($3.00) | ($1.46) | ($2.57) | ($0.31) | ($0.31) | ($0.76) |
| Growth | 11.7% | -69.1% | 105.2% | -43.0% | 730.5% | 0.0% | -59.2% | -3.8% |
| Diluted EPS [+] | ($1.04) | ($0.93) | ($3.00) | ($1.46) | ($2.57) | ($0.31) | ($0.31) | ($0.76) |
| Growth | 11.7% | -69.1% | 105.2% | -43.0% | 730.5% | 0.0% | -59.2% | -3.8% |
| |
| Shares outstanding (basic) [+] | 4.5 | 4.4 | 4.4 | 4.4 | 4.3 | 42.7 | 42.1 | 41.4 |
| Growth | 0.9% | 0.4% | 1.4% | 1.0% | -89.9% | 1.3% | 1.7% | 1.6% |
| Shares outstanding (diluted) [+] | 4.5 | 4.4 | 4.4 | 4.4 | 4.3 | 42.7 | 42.1 | 41.4 |
| Growth | 0.9% | 0.4% | 1.4% | 1.0% | -89.9% | 1.3% | 1.7% | 1.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |